Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TFX · against 223 other Healthcare companies of similar size
Ranked #138 of 224 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 40–49, including TFX · Click a bar to see the companies
A mix: stronger free cash flow yield, but weaker earnings yield than most Healthcare peers.
| Metric | TFX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 221 reported | -0.4% | 2.5% | 29% | 30% | |
| EBITDA yieldHigher is better · 222 reported | 4.7% | 4.6% | 52% | 50% | |
| Free cash flow yieldHigher is better · 125 reported | 5.5% | 1.2% | 85% | 20% | |
| Book yieldHigher is better · 223 reported | 49.0% | 24.5% | 82% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 22.0B CNY (≈$3.1B) | 96 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 138 | 10.5B USD | 44 | 56 | |
| 138 | 321.5B INR (≈$3.9B) | 44 | 70 | |
| 138 | 871.6B INR (≈$10.5B) | 44 | 66 | |
| 138 | 5.7B USD | 44 | 38 | |
| 138 | 5.9B USD | 44 | 39 | |
| 144 | 40.3B SEK (≈$4.0B) | 43 | 79 | |
| 144 | 4.6B USD | 43 | 65 | |
| 146 | 5.1B USD | 42 | 52 | |
| 146 | 5.8B USD | 42 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score